How big is the weight loss therapeutics market?

The global weight loss therapeutics market is expected to reach a staggering USD 14,978.1 million by 2030, growing at a CAGR of 24.3% from 2024-2031.

What are the key drivers of weight loss therapeutics market growth?

The rising prevalence of chronic diseases like obesity and diabetes, increasing demand for point-of-care treatment, and advancements in therapeutic development are key drivers fueling market expansion.

Which region is leading the weight loss therapeutics market?

North America currently dominates the market, holding a 42.3% share in 2022. This is due to the strong presence of major players, rising healthcare expenditure, and increasing awareness about weight management.

Who are the major players in the weight loss therapeutics market?

Leading players include F Hoffmann-la Roche Ltd, Currax Pharmaceuticals LLC, Viking Therapeutics, Pfizer Inc., and Eli Lilly and Company. These companies are actively involved in research, development, and marketing of weight loss drugs.